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Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study INTRODUCTION The Oxford regional prospective study is a population based inception cohort of children with type 1 diabetes designed to determine prospectively the natural course of microalbuminuria during childhood and adolescence. 1 Initial data indicated a cumulative prevalence of microalbuminuria of 40% after 11 years of diabetes, and this was predicted by poor glycaemic control but not blood pressure. 1 The prognostic value of microalbuminuria for progression to macroalbuminuria has not been adequately determined in a childhood cohort. We report on data from this study after up to 19 years of follow-up and focus on predictors for the development of microalbuminuria and macroalbuminuria.
METHODS
Oxford regional prospective study
The Oxford regional prospective study was established in 1986.
1 It identified children with type 1 diabetes aged under 16 over a 10 year period from the diabetes register and recruited children within three months of diagnosis. Case ascertainment for the register was over 95%. From 1986 to 1997, 91% (n=527) of eligible children were recruited at a mean age 8.8 (SD 4.0) years. To date the dropout rate is 9.6%. Mean duration of follow-up to date is 9.8 (3.8) years. Only 4% of the participants have been followed up for under three years, and 9% have over 15 years' follow-up. Microalbuminuria was treated with angiotensin converting enzyme inhibitors or β blockers in those aged over 18 with persistent microalbuminuria or hypertension, or both.
Annual assessments
Research nurses assessed participants annually from the first year of diagnosis and recorded height, weight, blood pressure, and collected three consecutive early morning urine specimens for the measurement of albumin:creatinine ratio. Blood samples were collected for centralised measurement of glycated haemoglobin (HbA 1c ). See bmj.com for definitions of microalbuminuria, persistent microalbuminuria, intermittent microalbuminuria, transient microalbuminuria, and macroalbuminuria.
Statistical methods
We averaged results of annual urine collections from each participant using the geometric mean, which were In those with a diagnosis of diabetes before the age of 5 (n=27), compared with those with a diagnosis at ages 5-11 (n=64) and after 11 (n=44), there was a longer interval between age at diagnosis to first appearance of microalbuminuria (8. . After 10 years of diabetes, in the group with a diagnosis before the age of 5 compared with the two other groups, cumulative prevalence of microalbuminuria was lower (age at diagnosis <5 years: 17.4% (9.8% to 25.0%); 5-10 years: 28.7% (21.7% to 35.7%); >11 years: 28.9% (20.5% to 37.3%); log rank test P=0.035). After 15 years of diabetes, however, cumulative prevalence was similar in the three groups (<5 years: 43.0% (25.0% to 61.0%); 5-11 years: 45.7% (33.3% to 58.1%); and >11 years: 40.8% (27.2% to 54.4%); log rank test P=0.1, fig 2) .
Predictors for development of microalbuminuria Significant unadjusted correlates of microalbuminuria were poor glycaemic control (1.35, 1.24 to 1.47, P<0.001-that is, a 35% increased risk for a 1% rise in HbA 1c ), female sex (1.43, 1.02 to 2.01, P=0.04), diastolic blood pressure (1.02, 1.00 to 1.04, P=0.04), and younger age at diagnosis of diabetes (1.06, 1.01 to 1.10, P=0.01). Non-contributory variables included systolic blood pressure (1.01, 0.99 to 1.02, P=0.17) and history of smoking (1.32, 0.89 to 1.94, P=0.23). In a Cox model, the only modifiable adjusted predictor for the development of microalbuminuria was poor glycaemic control. Female sex was also associated with microalbuminuria.
Course of microalbuminuria
Of the 135 participants with microalbuminuria, 65 (48%) developed persistent microalbuminuria, 17 (13%) had intermittent microalbuminuria, and 53 (39%) had transient microalbuminuria, giving a cumulative prevalence of regression to the normoalbuminuric range of 51.9% (42.3% to 61.5%) after 4.9 years after the onset of microalbuminuria. Duration of diabetes was greater in participants with persistent Intervention with antihypertensive medication Twenty (15%) participants with microalbuminuria (13 with persistent microalbuminuria and seven with intermittent microalbuminuria and hypertension) were treated with an angiotensin converting enzyme inhibitor or a β blocker. Seven (35%) participants receiving treatment progressed to macroalbuminuria (and these were all previously categorised as having persistent microalbuminuria) compared with 11 (10%) with microalbuminuria not receiving treatment (χ 2 =9.5, P=0.002). See bmj.com.
DISCUSSION
In this inception cohort of people with childhood onset type 1 diabetes, the cumulative prevalence of microalbuminuria was 25.7% and 50.7% after 10 and 19 years of diabetes, respectively, and the cumulative prevalence of macroalbuminuria was 13.9% after 19 years.
Comparisons with other studies For microalbuminuria, the cumulative prevalence was significantly higher than that from an adult only inception cohort in which prevalence was nearly 34% after 18 years of follow-up and similar glycaemic exposure. 2 This prevalence is greater than previously reported in longitudinal childhood studies, [3] [4] [5] but those previous studies were clinic based, with variable duration of diabetes at inclusion compared with our cohort. The prevalence of macroalbuminuria of 13.9% was similar to that in the adult inception data but occurred at a much earlier age. No comparable data exist for children, although previous small clinic based studies indicate a prevalence of macroalbuminuria of 7-32%. [6] [7] [8] Implications of poor glycaemic control In children the goal should be improvement of glycaemic control from the onset of diabetes. The 2002 Diabetes UK audit, however, indicated that 48% of adolescents were not achieving HbA 1c concentrations less than 9%, 9 and the Hvidore study also recently reported that HbA 1c concentrations during adolescence were disappointing. 10 The poor levels of glycaemic control in our study reflect the high Other predictors of microalbuminuria Microalbuminuria occurred more frequently in females. This might be explained by data indicating a role for sex steroids in renal damage associated with diabetes 12 and associations between hyperandrogenism and abnormalities in the growth hormone insulinlike growth factor I axis in adolescent girls with microalbuminuria. 13 Cumulative prevalence of microalbuminuria at the end of follow-up was unaffected by age at diagnosis, though in those with a diagnosis before the age of 5 there was a longer interval to first appearance of microalbuminuria. Other data indicate that before the onset of microalbuminuria, the annual rate of rise of urinary albumin excretion increases after the age of 11, coinciding with the onset of puberty and adolescence. 14 
Transient microalbuminuria
Definition of regression of microalbuminuria is complicated by regression to the mean and duration of follow-up. Our data indicate that people who have microalbuminuria in one year but become normoalbuminuric in the next year might be at risk of recurrence in one to seven years.
Risk for macroalbuminuria
Only 18 patients developed macroalbuminuria, so predictors and comparison with the remainder of the cohort should be interpreted with caution. The only modifiable predictor for the development of macroalbuminuria was poor glycaemic control. Both persistent and intermittent microalbuminuria are important predictors in the transition to macroalbuminuria in children, and these factors are robust after sensitivity analyses. In contrast with findings from studies in adults, those taking angiotensin converting enzyme inhibitors had higher rates of progression to macroalbuminuria. Only 20 patients had started this treatment, however, and our study was not designed to determine the effects of treatment. See bmj.com.
Limitations of study
We collected annual urine samples on three consecutive days rather than spaced through the year. Annual assessment of urinary albumin:creatinine ratio, however, is based on the average of three measurements, which reduces measurement error and regression to the mean. The use of Cox models is associated with inherent problems, as it requires a strict cut off point for the definition of microalbuminuria and macroalbuminuria. We validated the outcomes with sensitivity analyses. Finally, we did not have sufficient data on variables such as insulin regimens, which may have had a confounding effect on the outcome.
Conclusion
There is higher cumulative prevalence of microalbuminuria with predominance of risk in females in people with childhood onset type 1 diabetes compared with data from those with adult onset disease. Our data indicate that microalbuminuria is not persistent in over half of cases. As this depends on duration of follow-up, however, further cases of intermittent microalbuminuria might occur with longer follow-up of those with "transient" microalbuminuria. The probability of progression to macroalbuminuria is remarkably similar to that in adult onset disease, but it occurs at an earlier age and in people with both intermittent and persistent microalbuminuria. There is a need to consider earlier different intervention strategies in those diagnosed with diabetes during childhood.
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